JPRN-UMIN000009046已完成1 期
Phase1 Study of nab-paclitaxel plus Cyclophosphamide in Metastatic Breast Cancer - ABC-BC01
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Patients with any history of serious drug reactions 2. Anamnesis of hypersensitivity to nab-paclitaxel and Cyclophosphamide 3. Active double cancer 4. Use of radiation or pre-and/or post-surgical cytotoxic drug within 3weeks before registration 5. Past radiotherapy more than 30% of hematopoietic bone marrow 6. Patients with serious complications 7. Serious peripheral neuropathy 8. Brain metastasis with symptom or brain metastasis needs medical treatment 9. Storage of pericardium liquid or storage of pleural effusion or ascites which needs drainage 10. With pregnancy, lactation or the possibility of pregnancy 11. Unsuitable judgement by physician
研究者
相似试验
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
已完成
不适用
A Phase I/II study of nab-Paclitaxel plus S-1 therapy in previously treated patients with refractory advanced non-small-cell lung cancerJPRN-UMIN000012966Depatment of Thoracic Oncology Osaka Medical Center for Cancer and Cardiovascular Diseases45
尚未招募
不适用
Phase II study of nab-paclitaxel combined with S-1 in patients with early breast cancer:A multicenter clinical trialearly breast cancerJPRN-UMIN000027216The University of Tokushima Graduate School80
已完成
2 期
PhaseII study of Nab-paclitaxel followed by EC as neoadjuvant chemotherapy for the operable breast cancerBreast cancerJPRN-UMIN000022931Rakuwakai Otowa Hospital Breast oncology department24
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30